Cargando…
Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations
Predicting brain pharmacokinetics is critical for central nervous system (CNS) drug development yet difficult due to ethical restrictions of human brain sampling. CNS pharmacokinetic (PK) profiles are often altered in CNS diseases due to disease-specific pathophysiology. We previously published a co...
Autores principales: | Saleh, Mohammed A. A., Loo, Chi Fong, Elassaiss-Schaap, Jeroen, De Lange, Elizabeth C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405486/ https://www.ncbi.nlm.nih.gov/pubmed/34142308 http://dx.doi.org/10.1007/s10928-021-09768-7 |
Ejemplares similares
-
Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC(50) Values in Aging and Alzheimer’s Disease, Using the Physiologically Based LeiCNS-PK3.0 Model
por: Saleh, Mohammed A. A., et al.
Publicado: (2022) -
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells
por: Saleh, Mohammed A.A., et al.
Publicado: (2023) -
The Extension of the LeiCNS-PK3.0 Model in Combination with the “Handshake” Approach to Understand Brain Tumor Pathophysiology
por: Hirasawa, Makoto, et al.
Publicado: (2022) -
On Chip Analysis of CNS Lymphoma in Cerebrospinal Fluid
por: Turetsky, Anna, et al.
Publicado: (2015) -
Fluids and Barriers of the CNS: a new journal encompassing Cerebrospinal Fluid Research
por: Jones, Hazel C, et al.
Publicado: (2011)